MX2010004759A - Piperidinas 4,4-disustituidas como inhibidoras de renina. - Google Patents

Piperidinas 4,4-disustituidas como inhibidoras de renina.

Info

Publication number
MX2010004759A
MX2010004759A MX2010004759A MX2010004759A MX2010004759A MX 2010004759 A MX2010004759 A MX 2010004759A MX 2010004759 A MX2010004759 A MX 2010004759A MX 2010004759 A MX2010004759 A MX 2010004759A MX 2010004759 A MX2010004759 A MX 2010004759A
Authority
MX
Mexico
Prior art keywords
disubstituted
disubstituted piperidines
salts
piperidines
piperidinesof
Prior art date
Application number
MX2010004759A
Other languages
English (en)
Inventor
Peter Herold
Robert Mah
Christiane Marti
Stefan Stutz
Stjepan Jelakovic
Vincenzo Tschinke
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2010004759A publication Critical patent/MX2010004759A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La solicitud se refiere a piperidinas 4,4-disustituidas de la fórmula general (I) y sus sales, de preferencia sus sales farmacéuticamente aceptables, en donde R2 tiene los significados explicados en la descripción, a un proceso para su preparación, y al uso de estos compuestos como medicamentos, en especial como inhibidores de renina.
MX2010004759A 2007-11-02 2008-10-31 Piperidinas 4,4-disustituidas como inhibidoras de renina. MX2010004759A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07119884 2007-11-02
PCT/EP2008/064767 WO2009056617A2 (en) 2007-11-02 2008-10-31 4,4-disubstituted piperdines as renin inhibitors

Publications (1)

Publication Number Publication Date
MX2010004759A true MX2010004759A (es) 2010-05-19

Family

ID=39204939

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004759A MX2010004759A (es) 2007-11-02 2008-10-31 Piperidinas 4,4-disustituidas como inhibidoras de renina.

Country Status (13)

Country Link
US (1) US20100267713A1 (es)
EP (1) EP2215088A2 (es)
JP (1) JP2011503022A (es)
KR (1) KR20100075590A (es)
CN (1) CN101918398A (es)
AR (1) AR069145A1 (es)
AU (1) AU2008320806A1 (es)
BR (1) BRPI0819352A2 (es)
CA (1) CA2699889A1 (es)
EA (1) EA201000720A1 (es)
MX (1) MX2010004759A (es)
TW (1) TW200934499A (es)
WO (1) WO2009056617A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8389511B2 (en) 2007-12-19 2013-03-05 Dainippon Sumitomo Pharma Co., Ltd. Bicyclic heterocyclic derivative
CN102482256B (zh) 2009-06-24 2014-11-26 大日本住友制药株式会社 N-取代的环状氨基衍生物
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ315677A (en) * 1995-09-07 2000-02-28 F 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US6197959B1 (en) * 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
TW200833687A (en) * 2005-03-31 2008-08-16 Speedel Experimenta Ag Substituted piperidines
TW200804359A (en) * 2006-01-19 2008-01-16 Speedel Experimenta Ag Substituted 4-phenylpiperidines

Also Published As

Publication number Publication date
AR069145A1 (es) 2009-12-30
BRPI0819352A2 (pt) 2015-04-22
CA2699889A1 (en) 2009-05-07
AU2008320806A1 (en) 2009-05-07
TW200934499A (en) 2009-08-16
EP2215088A2 (en) 2010-08-11
KR20100075590A (ko) 2010-07-02
EA201000720A1 (ru) 2010-10-29
CN101918398A (zh) 2010-12-15
US20100267713A1 (en) 2010-10-21
WO2009056617A3 (en) 2009-07-09
JP2011503022A (ja) 2011-01-27
WO2009056617A2 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
MX2011012017A (es) Nuevos derivados azaciclicos como inhibidores de lipasa sensible a las hormonas (hsl).
MX2010006799A (es) Benzofuropirimidinonas como inhibidores de la proteina cinasa.
TW200613274A (en) Organic compounds
MY149731A (en) Compounds
PT2178881E (pt) Novos derivados de 6-triazolopiridazina-sulfanil benzotiazole e benzimidazole, seu método de preparação, sua aplicação como medicamentos, composições farmacêuticas e nova utilização como inibidores de met
MX2012004311A (es) Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes.
MY148258A (en) Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
GEP20125487B (en) Organic compounds and their use
MX2009003939A (es) Derivados de imidazolona e imidazolidinona como inhibidores de la 11-beta-hidroxiesteroide deshidrogenasa de tipo 1 para diabetes.
TW200702330A (en) 3,4,5-Substituted piperidines
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
DE602006021539D1 (en) Morpholine als 5ht2c-agonisten
MX2010005824A (es) Derivados de aminotiazol.
TW200616958A (en) New alkyl-pyridines as 11-beta inhibitors for diabetes
MX2009013501A (es) Compuestos piperidinicos y sus usos.
UA99787C2 (en) Lactams as beta secretase inhibitors
TN2010000038A1 (en) Organic compounds
GEP20125407B (en) New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2009126861A3 (en) Triazolopyridine compounds useful as dgat1 inhibitors
NO20085052L (no) 4-((fluorofenoksyl)fenylmetyl)piperidin metansulfonat: anvendelser, synteseprosess og farmasoytiske sammensetninger
MY161749A (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
MX2010006108A (es) Inhibidores de estearoil-coa-desaturasa.
WO2008087654A3 (en) PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1
MX2009012518A (es) Derivados de piperidina 4,4-disubstituidos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal